English
Home > Products > Benzyltriethylammonium

China Benzyltriethylammonium Factory

So as to give you ease and enlarge our company, we also have inspectors in QC Team and assure you our greatest support and product or service for Benzyltriethylammonium,CAS NO 1836-42-6,1836-42-6, The principle of our company is to provide high-quality products, professional service, and honest communication. Welcome all friends to place trial order for creating a long-term business relationship.
Benzyltriethylammonium, We are going to supply much better items with diversified designs and professional services. We sincerely welcome friends from over the world to visit our company and cooperate with us on the basis of long-term and mutual benefits.

Related Products

Hot Products

  • Sotagliflozin

    Sotagliflozin

    Product Name:Sotagliflozin
    Molecular Formula:C21H25ClO5S
    Molecular Weight;424.94
    CAS Registry Number;1018899-04-1
  • Sorafenib tosylate

    Sorafenib tosylate

    Product Name:Sorafenib tosylate
    Molecular Formula:C28H24ClF3N4O6S
    Molecular Weight;637.03
    CAS Registry Number;475207-59-1
  • Methyl salicylate

    Methyl salicylate

    Product Name:Methyl salicylate
    Molecular Formula:C8H8O3
    Molecular Weight;152.15
    CAS Registry Number;119-36-8
  • (1-methylpiperidin-4-yl)(pyrrolidin-1-yl)methanone

    (1-methylpiperidin-4-yl)(pyrrolidin-1-yl)methanone

    Product Name:(1-methylpiperidin-4-yl)(pyrrolidin-1-yl)methanone
    Molecular Formula:C11H20N2O
    Molecular Weight:196.29
    CAS Registry Number:613678-14-1
  • Tegoprazan

    Tegoprazan

    Product Name:Tegoprazan
    Molecular Formula:C20H19F2N3O3
    Molecular Weight;387.38
    CAS Registry Number;942195-55-3
  • Cefotetan disodium

    Cefotetan disodium

    Product Name:Cefotetan disodium
    Molecular Formula:C17H18N7NaO8S4
    Molecular Weight;599.6
    CAS Registry Number;74356-00-6
  • Related Blog
  • Reviews

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications. Our products are produced under strict procedures and cGMP (Current Good Manufacturing Practices). In addtion, we can also customize new pharmaceutical compounds for new drugs.

  • What are pharmaceutical intermediates?

    Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept